Sigma-1 receptor antagonism as opioid adjuvant strategy: enhancement of opioid antinociception without increasing adverse effects.

Alba Vidal-Torres,B. de la Puente,M. Rocasalbas,C. Touriño,S. Bura,B. Fernández-Pastor,L. Romero,X. Codony,D. Zamanillo,H. Buschmann,M. Merlos,J. Baeyens,R. Maldonado,J. Vela
DOI: https://doi.org/10.1016/j.ejphar.2013.04.018
IF: 5.195
2013-07-05
European Journal of Pharmacology
Abstract:
What problem does this paper attempt to address?